Clinical Trial Update: Testing for Safety and Colorectal Cancer Preventive Effects of ONC201 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the safety and potential colorectal cancer preventive effects of ONC201, sponsored by the National Cancer Institute, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Familial Adenomatous Polyposis

Drugs mentioned

• ONC201 (ONC201)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colorectal Adenomatous Polyp, Colorectal Carcinoma | Phase 1 | Status: RECRUITING